Tumor-Specific Delivery of KRAS siRNA With iRGD-exosomes Efficiently Inhibits Tumor Growth

ExRNA
doi 10.1186/s41544-019-0034-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Plasmid-Based STAT3-siRNA Efficiently Inhibits Breast Tumor Growth and Metastasis in Mice

Neoplasma
Cancer Research
2011English

Cetuximab Inhibits the Growth of Mucinous Ovarian Carcinoma Tumor Cells Lacking KRAS Gene Mutations

Oncology Reports
MedicineCancer ResearchOncology
2012English

Targeted Silencing of CXCL1 by siRNA Inhibits Tumor Growth and Apoptosis in Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Mannose Inhibits Tumor Growth and Increases Tumor Chemosensitivity

Cancer Discovery
Oncology
2018English

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth in Vivo

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2017English

Direct Targeting of Oncogenic RAS Mutants With a Tumor-Specific Cytosol-Penetrating Antibody Inhibits RAS Mutant–driven Tumor Growth

Science advances
Multidisciplinary
2020English

A Recombinant Chimeric Protein Specifically Induces Mutant KRAS Degradation and Potently Inhibits Pancreatic Tumor Growth

Oncotarget
Oncology
2016English

Tumor-Penetrating Delivery of siRNA Against TNFα to Human Vestibular Schwannomas

Scientific Reports
Multidisciplinary
2017English

Corrigendum to “Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-Specific RNA Aptamers Inhibits Tumor Growth in Vivo”

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy